$SEM

CHERNOW DAVID S sold (to issuer) $10.8M of SEM

CHERNOW DAVID S (VICE CHAIRMAN) sold (to issuer) 656,823 shares of SELECT MEDICAL HOLDINGS CORP (SEM) at $16.50 ($10.84M total) on 2026-06-30.

Original reporting
SEC EDGAR · CHERNOW DAVID S
Published Jul 1, 2026, 6:19 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 6:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SEM
Neutral
medium confidence
Mentioned
$SEM
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SEMNeutralLow
01

Why it matters

The newest concrete fact is the disclosed sale size ($10.84M) and post-transaction holdings (113,421 shares). This is primarily a sentiment/positioning datapoint, not a fundamental catalyst.

02

Market read

Traders may monitor insider activity as a sentiment input, but the filing does not introduce guidance, legal, or operational changes.

03

What to watch

No 10b5-1 plan is cited; traders may still treat the lack of a plan as marginally more informative, but the filing lacks context on motives or future selling.

Relevance 7/10Novelty 6/10Timing: filed after-hours on 2026-07-01; reflects 2026-06-30 transaction

Background

SEC Form 4 reports an insider transaction by David S. Chernows (vice chairman/director/officer) for Select Medical Holdings.

Company-level read

Ticker impact

$SEMNeutralMedium confidence
Context

Select Medical Holdings vice chairman David S. Chernows sold 656,823 shares to the issuer at $16.50 on 2026-06-30, per Form 4.

Expected impact

Low near-term impact; any effect is likely noise unless paired with other insider selling or guidance changes.

Evidence & confidence

The filing is a Form 4 insider transaction with defined trade size and price, but it does not include new operating, guidance, or regulatory information.

Market effects

Minimal read-through to healthcare services/rehab sector absent any operational or regulatory catalyst.

No clear regional spillover; company-specific insider transaction only.

No global linkage indicated.

Counterpoint

Because the sale is to the issuer (often tied to buyback mechanics), it may be administrative rather than a bearish view on the stock.

Key entities

  • SELECT MEDICAL HOLDINGS CORP

    Subject of the Form 4 insider transaction; vice chairman David S. Chernows sold shares to the issuer.

  • CHERNOW DAVID S

    Vice chairman/officer/director who sold 656,823 shares at $16.50 on 2026-06-30.

Related articles

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law or fiduciary-duty issues in deals involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale for $16.50/share, and TopBuild’s proposed acquisition by QXO. The firm also flagged QXO’s merger with TopBuild and said it may seek higher consideration or additional disclosures.

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law violations and fiduciary-duty breaches involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale to a consortium led by its executives/directors for $16.50/share, and TopBuild’s proposed deal with QXO. TopBuild holders would choose $505 cash or 20.2 QXO shares per share.